Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the third leading cause of cancer-related death. sorafenib is used as a standard therapy to treat HCC. mesenchymal stromal cells (MSCs) have also been used to suppress HCC. Here we investigate the development of a xeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajighasemlou, Saieh, Pakzad, Saeedreza, Ai, Jafar, Muhammadnejad, Samad, Mirmoghtadaei, Milad, Hosseinzadeh, Faezeh, Gharibzadeh, Safoora, Kamali, Amir, Ahmadi, Akbar, Verdi, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103601/
https://www.ncbi.nlm.nih.gov/pubmed/29936790
http://dx.doi.org/10.22034/APJCP.2018.19.6.1627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103601/
https://www.ncbi.nlm.nih.gov/pubmed/29936790
http://dx.doi.org/10.22034/APJCP.2018.19.6.1627

Ejemplares similares